Analysis of immunomodulatory activities of aqueous humor from eyes of mice with experimental autoimmune uveitis

Journal of Immunology

Volumn 164, Issue 3, 2000, Pages 1185-1192

  Ohta, Kouichi ^a   Wiggert, Barbara ^b   Yamagami, Satoru ^a   Taylor, Andrew W ^a   Streilein, J Wayne ^a  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AQUEOUS HUMOR; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; FEMALE; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PHOTORECEPTOR; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; UVEITIS;

EID: 0034142003     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.3.1185     Document Type: Article

References (48)

1. Streilein, J. W. 1993. Immune privilege as the result of local tissue barriers and immunosuppressive microenvironments. Curr. Opin. Immunol. 5:428.
2. Kaiser, C. J., B. R. Ksander, and J. W. Streilein. 1989. Inhibition of lymphocyte proliferation of aqueous humor. Reg. Immunol. 2:42.
3. Cousins, S. W., W. B. Trattler, and J. W. Steilein. 1991. Immune privilege and suppression of immunogenic inflammation in the anterior chamber of the eye. Curr. Eye Res. 10:287.
4. Taylor, A. W., P. Alard, D. G. Yee, and J. W. Streilein. 1997. Aqueous humor induces transforming growth factor-β (TGF-β)-producing T-cells. Curr. Eye Res. 16:900.
5. Nishida, T., K. Namba, and A. W. Taylor. 1999. Regulatory T cells induced by aqueous humor factors inhibit induction of experimental autoimmune uveoretinitis. Invest. Ophthalmol. Visual Sci. 40(Suppl.):S860.
6. Granstein, R., R. Staszewski, T. L. Knisely, E. Zeira, R. Nazareno, M. Latina, and D. M. Albert. 1990. Aqueous humor contains transforming growth factor-β and small (<3500 daltons) inhibitor of thymocyte proliferation. J. Immunol. 144: 3021.
7. Cousins, S. W., M. M. McCabe, D. Danielpour, and J. W. Streilein. 1991. Identification of transforming growth factor-β as immunosuppressive factor in aqueous humor. Invest. Ophthalmol. Visual Sci. 32:2201.
8. Taylor, A. W., J. W. Streilein, and S. Cousins. 1992. Identification of α-melanocyte stimulating hormone as a potential immunosuppressive factor in aqueous humor. Curr. Eye Res. 11:1199.
9. Taylor, A. W., J. W. Streilein, and S. Cousins. 1994. Vasoactive intestinal peptide contributes to the immunosuppressive activity of normal aqueous humor. J. Immunol. 153:1080.
10. Taylor, A. W., D. G. Yee, and J. W. Streilein. 1998. Suppression of nitric oxide generated by inflammatory macrophages by calcitonin gene-related peptide in aqueous humor. Invest. Ophthalmol. Visual Sci. 39:1372.
11. Apte, R. S., D. Sinha, E. Mayhew, G. J. Wistow, and J. Y. Niederkorn. 1998. Role of macrophage migration inhibitory factor in inhibiting NK cell activity and preserving immune privilege. J. Immunol. 160:5693.
12. Knisely, T. L., J. Hosoi, R. Nazareno, and R. D. Granstein. 1994. The presence of biologically significant concentrations of glucocorticoids but little or no cortisol binding globulin with aqueous humor: relevance to immune privilege in the anterior chamber of the eye. Invest. Ophthalmol. Visual Sci. 35:3711.
13. Helbig, H., K. L. Kittredge, M. Coca-Prados, J. Davis, A. G. Palestine, and R. B. Nussenblatt. 1991. Mammalian ciliary-body epithelial cells in culture produce transforming growth factor-β. Graefe's Arch. Clin. Exp. Ophthalmol. 229: 84.
14. Knisely, T. L., P. A. Bleicher, C. A. Vibbard, and R. D. Granstein. 1991. Production of latent transforming growth factor-β and other inhibitory factors by cultured murine iris and ciliary body cells. Curr. Eye Res. 10:761.
15. Streilein, J. W., and D Bradley. 1991. Analysis of immunosuppressive properties of iris and ciliary body cells and their secretory products. Invest. Ophthalmol. Visual Sci. 32: 2700.
16. Ganley, J. P. 1980. Uveitis. In Ir Current Ocular Therapy. F. T. Freunfelder and F. H. Roy, eds. Saunders, Philadelphia, p. 485.
17. Rosenbaum, J. T., H. O. McDevitt, R. B. Guss, and P. R. Egbert. 1980. Endotoxin-induced uveitis in rats as a model for human disease. Nature 286:611.
18. Caspi, R. R., F. G. Roberge, C. C. Chan, B. Wiggert, G. J. Chader, L. A. Rozenszajn, Z. Lando, and R. B. Nussenblatt. 1988. A new model of autoimmune disease: experimental autoimmune uveoretinitis induce in mice with two different relinal antigens. J. Immunol. 140:1490.
19. Bora, N. S., M. C. Kim, N. H. Kabeer, S. C. Simpson, M. T. Tandhasetti, T. P. Cirrito, A. D. Kaplan, and H. J. Kaplan. 1995. Experimental autoimmune anterior uveitis: induction with melanin-associated antigen from the iris and ciliary body. Invest. Ophthalmol. Visual Sci. 36:1056.
20. Hara, Y., R. R. Caspi, B. Wiggart, C. C. Chan, G. A. Wilbanks, and J. W. Streilein. 1992. Suppression of experimental autoimmune uveitis in mice by induction of anterior chamber-associated immune deviation with interphotoreceptor retinoid binding protein. J. Immunol. 148:1685.
21. Ohta, K., B. Wiggert, A. W. Taylor, and J. W. Streilein. 1999. Effects of experimental ocular inflammation on ocular immune privilege. Invest. Ophthalmol. Visual Sci. 40:2010.
22. Redmond, T. M., B. Wiggert, F. A. Robey, N. Y. Nguyen, M. S. Lewis, L. Lee, and G. J. Chader. 1985. Isolation and characterization of monkey interphotoreceptor retinoid-binding protein, an unique extra-cellular matrix component of the retina. Biochemistry 24:787.
23. De Kozak, Y., J. Stainte-Laudy, J. Benveniste, and J.-P. Faure. 1981. Evidence for immediate hypersensitivity phenomena in experimental autoimmune uveoretinitis. Eur. J. Immunol. 11:612.
24. Chan, C. C., R. R. Caspi, M. Ni, W. C. Leake, B. Wiggert, G. J. Chader, and R. B. Nussenblatt. 1990. Pathology of experimental autoimmune uveoretinitis in mice. J. Autoimmun. 3:247.
25. Gilman, M. 1993. Ribonuclease protection assay. In Current Protocols in Molecular Biology, Vol. 1. F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Stuhl, eds. Wiley, New York, p. 4.7.1.
26. Niederkorn, J. Y. 1990. Immune privilege and immune regulation in the eye. Adv. Immunol. 48:191.
27. Wilbanks, G. A., and J. W. Streilein. 1990. Distinctive humoral immune responses following anterior chamber and intravenous administration of soluble antigen: evidence for active suppression of IgG2-secreting B lymphocytes. Immunology 71:566.
28. Kaplan, H. J., and J. W. Streilein. 1977. Immune response to immunization via the anterior chamber of the eye. I. F1 lymphocyte-induced immune deviation. J. Immunol. 118:809.
29. Streilein, J. W., J. Y. Niederkorn, and J. A. Shadduck. 1980. Systemic immune unresponsiveness induced in adult mice by anterior chamber presentation of minor histocompatibility antigens. J. Exp. Med. 152:1121.
30. Wilbanks, G. A., and J. W. Streilein. 1990. Characterization of suppressor cells in anterior chamber-associated immune deviation (ACAID) induced by soluble antigen: evidence of two functionally and phenotypically distinct T-suppressor cell populations. Immunology 71:383.
31. Gery, I., M. Mochizuki, and R. B. Nussenblatt. 1986. Retinal specific antigens and immunopathogenic processes they provoke. Prog. Retinal Res. 5:72.
32. Hirano, T., S. Akira, T. Taga, and T. Kishimoto. 1990. Biological and clinical aspects of interleukin 6. Immunol. Today 12:443.
33. Murray, P. I., R. Hoekzema, M. A. C. van Haren, F. D. de Hon, and A. Kijlstra. 1990. Aqueous humor interleukin-6 levels in uveitis. Invest. Ophthalmol. Visual Sci. 31:917.
34. De Vos, A. F., M. A. C. van Haren, C. Verhargen, R. Hoekzema, and A. Kijilstra. 1994. Kinetics of intraocular tumor necrosis factor and interleukin-6 in endotoxin-induced uveitis in the rat. Invest. Ophthalmol. Visual Sci. 35:1100.
35. Norose, K., A. Yano, X. C. Wang, T. Tokushima, J. Umihira, A. Seki, M. Nohara, and K. Segawa. 1994. Dominance of activated T cells and interleukin-6 in aqueous humor in Vogt-Koyanagi-Harada disease. Invest. Ophthalmol. Visual Sci. 35:33.
36. Joseph, S. B., K. T. Miner, and M. Croft. 1998. Augmentation of naive, Th1 and Th2 effector CD4 responses by IL-6, IL-1 and TNF. Eur. J. Immunol. 28:277.
37. Reinhold, D., U. Bank, F. Buhling, U. Lendeckel, and S. Ansorge. 1995. Transforming growth factor-β1 inhibits interleukin 10 mRNA expression and production in pokeweed mitogen-stimulated peripheral blood mononuclear cells and T cells. J. Interferon Cytokine Res. 15:685.
38. Okuda, Y., S. Sakoda, C. C. A. Bernard, H. Fujimura, Y. Saeki, T. Kishimoto, and T. Yanagihara. 1998. IL-6-deficient mice are resistance to the induction of experimental autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein. Int. Immunol. 10:703.
39. Samoilova, E. B., J. L. Horton, B. Hilliard, T.-S. T. Liu, and Y. Chen. 1998. IL-6-deficient mice are resistance to experimental autoimmune encephalomyelitis: role of IL-6 in the activation and differentiation of autoreactive T cells. J. Immunol. 161:6480.
40. Mendel, I., A. Katz, N. Kozak, A. Ben-Nun, and M. Revel. 1998. Interleukin-6 functions in autoimmune encephalomyelitis: a study in gene-targeted mice. Eur. J. Immunol. 28:1727.
41. Gijbels, K., S. Brocker, J. S. Abrams, and L. Steinman. 1995. Administration of neutralizing antibodies to interleukin-6 (IL-6) reduces experimental autoimmune encephalomyelitis and its associated with elevated levels of IL-6 bioactivity in central nervous system and circulation. Mol. Med. 1:795.
42. Tilg, H., C. A. Dinarello, and J. W. Mier. 1997. IL-6 and APRs: antiinflammatory and immunosuppressive mediators. Immunol. Today 18:428.
43. Tilg, H., E. Trehu, M. B. Atkins, C. A. Dinarello, and J. W. Mier. 1994. Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood 83:113.
44. Marinkovic, S., J. P. Jahreis, G. G. Wong, and M. Baumann. 1989. IL-6 modulates the synthesis of a specific set of acute phase plasma proteins in vivo. J. Immunol. 142:808.
45. Rodriguez, M., K. D. Pavelko, C. W. McKinney, and J. L. Leibowitz. 1994. Recombinant human IL-6 suppresses demyelination in a vial model of multiple sclerosis. J. Immunol. 153:3811.
46. Zhou, D., A. Munster, and R. A. Winchurch. 1991. Pathogenic concentration of interleukin 6 inhibit T cell responses via induction of activation of TGF-β. FASEB J. 5:2582.
47. Agarwal, R. K., C. C. Chan, B. Wiggert, and R. R. Caspi. 1999. Pregnancy ameliorates induction and expression of experimental autoimmune uveitis. J. Immunol. 162:2648.
48. Kiefer, R., T. Schweitzer, S. Jung, K. V. Toyka, and H.-P. Hartung. 1998. Sequential expression of transforming growth factor-β1 by T-cells, macrophages, and microglia in rat spinal cord during autoimmune inflammation. J. Neuropathol. Exp. Neurol. 57:385.